发明名称 |
TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS |
摘要 |
The present disclosure provides novel compositions and methods for treating an infection by Middle East respiratory syndrome coronavirus (MERS-CoV). In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by MERS:CoV. |
申请公布号 |
US2017119859(A1) |
申请公布日期 |
2017.05.04 |
申请号 |
US201515314782 |
申请日期 |
2015.05.29 |
申请人 |
Ansun Biopharma, Inc. |
发明人 |
MOSS Ronald D. |
分类号 |
A61K38/47;C07K14/485;C12N9/24;A61K9/00 |
主分类号 |
A61K38/47 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating an infection by MERS-CoV in a patient, the method comprising administering to the patient an effective amount of an agent having sialidase activity. |
地址 |
San Diego CA US |